Literature DB >> 35622326

Immunoglobulin Gene Mutational Status Assessment by Next Generation Sequencing in Chronic Lymphocytic Leukemia.

Anne Langlois de Septenville1, Myriam Boudjoghra1, Clotilde Bravetti1,2, Marine Armand1,2, Mikaël Salson3, Mathieu Giraud3, Frederic Davi4,5.   

Abstract

B cell receptor (BcR) immunoglobulins (IG) display a tremendous diversity due to complex DNA rearrangements, the V(D)J recombination, further enhanced by the somatic hypermutation process. In chronic lymphocytic leukemia (CLL), the mutational load of the clonal BcR IG expressed by the leukemic cells constitutes an important prognostic and predictive biomarker. Here, we provide a reliable methodology capable of determining the mutational status of IG genes in CLL using high-throughput sequencing, starting from leukemic cell DNA or RNA.
© 2022. The Author(s).

Entities:  

Keywords:  Chronic lymphocytic leukemia; Immunoglobulin genes; Mutational status; Next generation sequencing; Somatic hypermutation analysis

Mesh:

Substances:

Year:  2022        PMID: 35622326     DOI: 10.1007/978-1-0716-2115-8_10

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  2 in total

1.  ARResT/Interrogate: an interactive immunoprofiler for IG/TR NGS data.

Authors:  Vojtech Bystry; Tomas Reigl; Adam Krejci; Martin Demko; Barbora Hanakova; Andrea Grioni; Henrik Knecht; Max Schlitt; Peter Dreger; Leopold Sellner; Dietrich Herrmann; Marine Pingeon; Myriam Boudjoghra; Jos Rijntjes; Christiane Pott; Anton W Langerak; Patricia J T A Groenen; Frederic Davi; Monika Brüggemann; Nikos Darzentas
Journal:  Bioinformatics       Date:  2017-02-01       Impact factor: 6.937

2.  ARResT/AssignSubsets: a novel application for robust subclassification of chronic lymphocytic leukemia based on B cell receptor IG stereotypy.

Authors:  Vojtech Bystry; Andreas Agathangelidis; Vasilis Bikos; Lesley Ann Sutton; Panagiotis Baliakas; Anastasia Hadzidimitriou; Kostas Stamatopoulos; Nikos Darzentas
Journal:  Bioinformatics       Date:  2015-08-06       Impact factor: 6.937

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.